Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial

IMPORTANCE: Although the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for EGFR gene mutation–positive non–small cell lung cancer is well established, optimal dosing remains to be established, especially in elderly or frail patients. OBJECTIVE: To investigate the efficacy a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Miyamoto, Shingo, Azuma, Koichi, Ishii, Hidenobu, Bessho, Akihiro, Hosokawa, Shinobu, Fukamatsu, Nobuaki, Kunitoh, Hideo, Ishii, Mari, Tanaka, Hiroshi, Aono, Hiromi, Nakahara, Yoshiro, Kusaka, Kei, Hosomi, Yukio, Kikuchi, Norihiro, Mori, Yoshiaki, Itani, Hidetoshi, Hamada, Akinobu, Yamada, Kazuhiko, Okamoto, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226294/
https://ncbi.nlm.nih.gov/pubmed/32407455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.1250
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados